Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DEMENTIA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT05830214
What this trial is testing

Digital Smartwatch Measurements as Potential Biomarkers for Remote Disease Tracking in ALS

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisMuscular Atrophy, Progressive+2 more
University of Alberta
Not applicableEnrolling By InvitationNCT05999084
What this trial is testing

Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry

Who this might be right for
Alzheimer Disease
Emory University 735
Early research (Phase 1)Study completedNCT02552147
What this trial is testing

Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism

Who this might be right for
Autism Spectrum DisorderAggressionIrritability
Yale University 8
Not applicableLooking for participantsNCT04956549
What this trial is testing

Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI)

Who this might be right for
Dementia of Alzheimer Type
Pennington Biomedical Research Center 144
Testing effectiveness (Phase 2)Ended earlyNCT03712787
What this trial is testing

An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
AbbVie 364
Testing effectiveness (Phase 2)Study completedNCT02507284
What this trial is testing

Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease

Who this might be right for
Irritable MoodHuntington's Disease
Azevan Pharmaceuticals 106
Testing effectiveness (Phase 2)Study completedNCT01044758
What this trial is testing

Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)

Who this might be right for
Mild Cognitive Impairment (MCI)
Johns Hopkins University 96
Not applicableStudy completedNCT01217541
What this trial is testing

Collaboration Between Department of Old Age Psychiatry and Nursing Homes

Who this might be right for
DementiaAlzheimer's DiseaseBehavioral Symptoms+1 more
Sykehuset Innlandet HF 700
Not applicableStudy completedNCT03622905
What this trial is testing

ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Functional Neuromodulation Ltd 74
Not applicableStudy completedNCT05102201
What this trial is testing

Effect of the Group-based Paro Intervention on Physiological and Psychological Outcomes

Who this might be right for
Dementia, MildDementia ModerateCognitive Impairment
National Tainan Junior College of Nursing 118
Post-approval studies (Phase 4)Study completedNCT01524367
What this trial is testing

Effect of Single-dose Dexmedetomidine on Emergence Excitement in Adults With Nasotracheal Intubation After Orthognathic Surgery

Who this might be right for
Agitation
Yonsei University 74
Early research (Phase 1)Study completedNCT01485965
What this trial is testing

Food Effect Study With SEN0014196 in Subjects With Huntington Disease

Who this might be right for
Huntington's Disease
Siena Biotech S.p.A. 26
Post-approval studies (Phase 4)Study completedNCT00948766
What this trial is testing

Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44

Who this might be right for
Alzheimer's Disease
Novartis 716
Post-approval studies (Phase 4)Study completedNCT04522739
What this trial is testing

Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
Emory University 25
Testing effectiveness (Phase 2)Ended earlyNCT01561430
What this trial is testing

Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 70
Not applicableStudy completedNCT03863041
What this trial is testing

Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.

Who this might be right for
Memory ComplaintAlzheimer DiseasePhosphorylated Metabolism Profile+1 more
Poitiers University Hospital 49
Post-approval studies (Phase 4)Study completedNCT01025466
What this trial is testing

Exelon Patch and Combination With Memantine Comparative Trial

Who this might be right for
Alzheimer's Disease
Inha University Hospital 206
Testing effectiveness (Phase 2)Looking for participantsNCT03503331
What this trial is testing

UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy

Who this might be right for
Alzheimer Disease
University of Alabama at Birmingham 160
Testing effectiveness (Phase 2)Study completedNCT00580931
What this trial is testing

Safety Study of Nicotinamide to Treat Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
University of California, Irvine 50
Testing effectiveness (Phase 2)Ended earlyNCT06199037
What this trial is testing

Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Shanghai Hengrui Pharmaceutical Co., Ltd. 46
Next Page